lonza

Swiss drug contract manufacturer Lonza said first-half core earnings gained 16.5 per cent on strong demand from biopharmaceutical companies.

[ZURICH] Swiss contract drug manufacturer Lonza said on Wednesday that a new production line in the Netherlands will produce ingredients for Moderna's Covid-19 vaccine, part of the US drugmaker's plan...

[ZURICH] Bain Capital and Cinven are acquiring Lonza's Specialty Ingredients division in a deal worth S$6.25 billion, the Swiss contract drug maker said on Monday, as it focuses on its faster-growing ...

CHEMICALS and biotech company Lonza Group will buy a sterile drug product fill-and-finish facility in Stein, Switzerland, from Novartis. Lonza, which has a secondary listing on the Singapore Exchange,...

CHEMICALS and biotech company Lonza Group will purchase a sterile drug product fill-and-finish facility in Stein, Switzerland, from Novartis.

SWISS biotech company Lonza has entered into an equal joint venture (JV) with Danish bioscience company Chr Hansen Holding to develop live biotherapeutic products (LBP) for pharma and biotech customer...

SWISS biotech company Lonza has entered into a 50/50 joint venture (JV) with Danish bioscience company Chr. Hansen to invest about 90 million euros (S$136.6 million) over three years to develop live b...

[FRANKFURT] Lonza Group, the world's largest custom maker of drug-ingredients, reported first-half profit that beat analyst estimates and said it will review its portfolio to boost profitability furth...